Iskender, B. Et Al. 2016. Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis. MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.416, no.1-2 , 71-84.

Iskender, B., Izgi, K., & CANATAN, H., (2016). Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis. MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.416, no.1-2, 71-84.

Iskender, BANU, Kenan Izgi, And HALİT CANATAN. "Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis," MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.416, no.1-2, 71-84, 2016

Iskender, BANU İ. Et Al. "Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis." MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.416, no.1-2, pp.71-84, 2016

Iskender, B. Izgi, K. And CANATAN, H. (2016) . "Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis." MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.416, no.1-2, pp.71-84.

@article{article, author={BANU İSKENDER İZGİ Et Al. }, title={Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis}, journal={MOLECULAR AND CELLULAR BIOCHEMISTRY}, year=2016, pages={71-84} }